A US observational study of nearly 7,000 adults with HIV-1 [...]
ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]
ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]